Mogilevski T, Hardy MY, Takahashi K, Smith R, Nguyen AL, Farmer A, Lindsay JO, Tye‐Din JA, Aziz Q, Gibson PR. Effects of Stress, Vagal Nerve Stimulation and Disease Activity on Circulating Cytokines, Quantified by an Ultrasensitive Technique, in Ulcerative Colitis: A Pilot Study. JGH Open. 2025;9(7):10.1002/jgh3.70206
Moscatelli OG, Russell AK, Henneken LM, Fothergill L, Motyer A, Reid H, Rossjohn J, Bryant V, Anderson RP, Hardy MY, Tye-Din JA. Blood-based T Cell Diagnosis of Celiac Disease. Gastroenterology. 2025;:10.1053/j.gastro.2025.05.022
Campbell DE, Mehr S, Moscatelli OG, Anderson RP, Tye-Din JA. Immune therapies in coeliac disease and food allergies: Advances, challenges, and opportunities. Seminars in Immunology. 2025;78:10.1016/j.smim.2025.101960
Singh M, Louie RHY, Samir J, Field MA, Milthorpe C, Adikari T, Mackie J, Roper E, Faulks M, Jackson KJL, Calcino A, Hardy MY, Blombery P, Amos TG, Deveson IW, Wende HV, Floor SN, Read SA, Shek D, Guerin A, Ma CS, Tangye SG, Di Sabatino A, Lenti MV, Pasini A, Ciccocioppo R, Ahlenstiel G, Suan D, Tye-Din JA, Goodnow CC, Luciani F. Expanded T cell clones with lymphoma driver somatic mutations accumulate in refractory celiac disease. Science Translational Medicine. 2025;17(798):10.1126/scitranslmed.adp6812
Hardy MY, Russell AK, Henneken LM, Tanner G, Bekes F, Brown I, Motyer A, Olechnowicz SWZ, Reid HH, Rossjohn J, Tye-Din JA. Purified oat protein can trigger acute symptoms linked to immune activation in coeliac disease patients but not histological deterioration. Gut. 2025;74(6):10.1136/gutjnl-2024-333589
Walker GJ, Mallitt K-A, Craig ME, Ashwood P, Barry SC, Brown JD, Caguicla J, Davis EA, Hamilton-Williams EE, Harrison LC, Haynes A, Huynh T, Martin G, McGorm KJ, Morahan G, Naing Z, Oakey H, Penno MAS, Sevendal A, Sinnott RO, Soldatos G, Thomson RL, Tye-Din J, Vuillermin PJ, Ward EJ, Wentworth JM, Colman PG, Couper JJ, Kim KW, Rawlinson WD, Cameron F, Day A, Lopez P, Anderson AJ, Hu W, Huynh D, Watson K, Beresford S, Bezuidenhout D, Brandrick S, Butterworth C, Catteau J, Griffiths H, Gwiazdzinski A, Hall C, Hulley A, Henneken L, Kludas R, Mateevici Y, Ramoso B, Roberts A, Tully A, Wood R, Binkowski S, Bui M, Gilbert A, Huang D, Karceva A, Mellor B-R, Neselli G, Ngui K, Nguyen T, Patel B, Prajitno V, Stone N, Tran T, Vaega S, Xu Y, Yau C, Battersby R, Brittain B, Foster C, Hope C, Leung P, Roth-Schulze A, Sadlon T, Tillett B, Wong YY, Zozaya-Valdes E, Cavenett L. SARS-CoV-2 Infection and Childhood Islet Autoimmunity. JAMA Pediatrics. 2025;179(5):10.1001/jamapediatrics.2024.6848
Glennan C, Chapman K, Wienholt L, Tye-Din JA. Variation in coeliac disease serology practices may impact biopsy-free diagnosis in Australasia. Pathology. 2025;:10.1016/j.pathol.2025.02.012
Lim JJ, Jones CM, Loh TJ, Dao HT, Tran MT, Tye-Din JA, La Gruta NL, Rossjohn J. A naturally selected αβ T cell receptor binds HLA-DQ2 molecules without co-contacting the presented peptide. Nature Communications. 2025;16(1):10.1038/s41467-025-58690-w
Lacorcia M, Bhattacharjee P, Foster A, Hardy MY, Tye-Din JA, Karas JA, Wentworth JM, Cameron FJ, Mannering SI. BASTA, a simple whole-blood assay for measuring β cell antigen–specific CD4+ T cell responses in type 1 diabetes. Science Translational Medicine. 2025;17(790):10.1126/scitranslmed.adt2124
Daveson AJM, Stubbs R, Polasek TM, Isola J, Anderson R, Tye-Din JA, Schoeman M, Lionnet C, Mei SLCY, Mihajlović J, Wirth M, Peelen E, Schreieck A, Kohlhof H, Vitt D, Muehler A, Buriánek F. Safety, clinical activity, pharmacodynamics, and pharmacokinetics of IMU-856, a SIRT6 modulator, in coeliac disease: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial. The Lancet Gastroenterology & Hepatology. 2025;10(1):10.1016/s2468-1253(24)00248-6
